DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit cerebral venous blood in 1974, studied for its role in neuroendocrine signaling, hypothalamic-pituitary axis regulation, and sleep architecture research. Published research spanning five decades has characterized DSIP as a neuropeptide small enough to cross the blood-brain barrier directly — a property that distinguishes it from larger peptides in CNS research applications. Studies have examined DSIP's capacity to attenuate corticotropin-releasing factor (CRF) signaling, buffering stress-axis feedback mechanisms in research models. Additional research has explored its influence on LH, GH, and TSH secretion patterns in neuroendocrine research settings, suggesting a compound with broad hypothalamic-pituitary regulatory effects in preclinical studies. Research has also examined DSIP's role in slow-wave sleep architecture in animal models, where it was first characterized. These sleep architecture effects have been studied alongside its stress-axis modulation properties in research examining the intersection of neuroendocrine function and sleep physiology. For researchers studying hypothalamic-pituitary axis regulation, neuroendocrine signaling, or sleep architecture mechanisms, DSIP offers one of the longest-standing research profiles among naturally occurring neuropeptides. For research use only.
Batch documentation ships with every order. To match your vial's lot number, request the current lot COA from the product page.